Intervention Review

Lamotrigine versus carbamazepine monotherapy for epilepsy

  1. Carrol L Gamble1,*,
  2. Paula R Williamson1,
  3. Anthony G Marson2

Editorial Group: Cochrane Epilepsy Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 30 JUN 2007

DOI: 10.1002/14651858.CD001031.pub2

Database Title

Additional Information

How to Cite

Gamble CL, Williamson PR, Marson AG. Lamotrigine versus carbamazepine monotherapy for epilepsy. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD001031. DOI: 10.1002/14651858.CD001031.pub2.

Author Information

  1. 1

    University of Liverpool, Centre for Medical Statistics and Health Evaluation, Liverpool, UK

  2. 2

    Clinical Sciences Centre for Research & Education, University Department of Neurological Science, Liverpool, Merseyside, UK

*Carrol L Gamble, Centre for Medical Statistics and Health Evaluation, University of Liverpool, Shelley's Cottage, Brownlow Street, Liverpool, L69 3GS, UK. c.gamble@liv.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 7 OCT 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (58K)Standard (406K)Full (518K)

  1. Current Version

    Lamotrigine versus carbamazepine monotherapy for epilepsy

    Carrol L Gamble, Paula R Williamson and Anthony G Marson

    Article first published online: 7 OCT 2009 | DOI: 10.1002/14651858.CD001031.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Lamotrigine versus carbamazepine monotherapy for epilepsy

    CL Preston, AG Marson and PR Williamson

    Article first published online: 19 OCT 2005 | DOI: 10.1002/14651858.CD001031

View Full Article (HTML) Summary (58K)Standard (406K)Full (518K)